AC Immune Current Valuation vs. Price To Book
| ACIU Stock | USD 3.40 0.01 0.29% |
For AC Immune profitability analysis, we use financial ratios and fundamental drivers that measure the ability of AC Immune to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well AC Immune utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between AC Immune's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of AC Immune over time as well as its relative position and ranking within its peers.
ACIU |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AC Immune. If investors know ACIU will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AC Immune listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.45) | Revenue Per Share 0.425 | Quarterly Revenue Growth 14.8 K | Return On Assets (0.12) | Return On Equity (0.31) |
The market value of AC Immune is measured differently than its book value, which is the value of ACIU that is recorded on the company's balance sheet. Investors also form their own opinion of AC Immune's value that differs from its market value or its book value, called intrinsic value, which is AC Immune's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AC Immune's market value can be influenced by many factors that don't directly affect AC Immune's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AC Immune's value and its price as these two are different measures arrived at by different means. Investors typically determine if AC Immune is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AC Immune's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
AC Immune Price To Book vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining AC Immune's current stock value. Our valuation model uses many indicators to compare AC Immune value to that of its competitors to determine the firm's financial worth. AC Immune is rated below average in current valuation category among its peers. It is rated below average in price to book category among its peers . The ratio of Current Valuation to Price To Book for AC Immune is about 70,624,604 . Price To Book Ratio is likely to drop to 2.11 in 2024. Comparative valuation analysis is a catch-all technique that is used if you cannot value AC Immune by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.ACIU Current Valuation vs. Competition
AC Immune is rated below average in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is presently estimated at about 3.17 Billion. AC Immune holds roughly 162.25 Million in current valuation claiming about 5% of equities under Health Care industry.
ACIU Price To Book vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
AC Immune |
| = | 162.25 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
AC Immune |
| = | 2.30 X |
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
ACIU Price To Book Comparison
AC Immune is currently under evaluation in price to book category among its peers.
AC Immune Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in AC Immune, profitability is also one of the essential criteria for including it into their portfolios because, without profit, AC Immune will eventually generate negative long term returns. The profitability progress is the general direction of AC Immune's change in net profit over the period of time. It can combine multiple indicators of AC Immune, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -51 K | -48.5 K | |
| Operating Income | -53.6 M | -50.9 M | |
| Net Loss | -54.2 M | -51.5 M | |
| Income Before Tax | -54.2 M | -51.5 M | |
| Total Other Income Expense Net | -599 K | -569 K | |
| Net Loss | -63.7 M | -60.5 M | |
| Net Loss | -54.2 M | -51.5 M | |
| Income Tax Expense | 10 K | 9.5 K | |
| Interest Income | 1 M | 1.2 M | |
| Net Interest Income | 868 K | 1.1 M | |
| Change To Netincome | 3.7 M | 3.9 M | |
| Net Loss | (0.64) | (0.67) | |
| Income Quality | 1.11 | 0.73 | |
| Net Income Per E B T | 1.00 | 1.10 |
ACIU Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on AC Immune. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of AC Immune position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the AC Immune's important profitability drivers and their relationship over time.
Use AC Immune in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AC Immune position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AC Immune will appreciate offsetting losses from the drop in the long position's value.AC Immune Pair Trading
AC Immune Pair Trading Analysis
The ability to find closely correlated positions to AC Immune could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AC Immune when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AC Immune - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AC Immune to buy it.
The correlation of AC Immune is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AC Immune moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AC Immune moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AC Immune can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your AC Immune position
In addition to having AC Immune in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Apparel Thematic Idea Now
Apparel
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Apparel theme has 49 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Apparel Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for ACIU Stock Analysis
When running AC Immune's price analysis, check to measure AC Immune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AC Immune is operating at the current time. Most of AC Immune's value examination focuses on studying past and present price action to predict the probability of AC Immune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AC Immune's price. Additionally, you may evaluate how the addition of AC Immune to your portfolios can decrease your overall portfolio volatility.